Pentagon Restores $1.27 Billion for 34 Military Medical Research Programs
March 25, 2026 · 2 min read
Claire Cummings
The Consolidated Appropriations Act of 2026, signed February 3, restored $1.27 billion in funding across 34 Congressionally Directed Medical Research Programs — the Defense Department's sprawling portfolio of competitive grants covering everything from breast cancer therapeutics to traumatic brain injury rehabilitation.
Where the Biggest Dollars Land
The largest allocations target the broadest research portfolios. The Peer Reviewed Medical Research Program received $370 million to cover 52 eligible conditions, from chronic pain to rare diseases. The Peer Reviewed Cancer Research Program got $165 million across 20 cancer types. Breast Cancer research commands $145 million, followed by Prostate Cancer at $75 million and Ovarian Cancer at $50 million.
The full breakdown reveals remarkable scope: $40 million each for ALS, Melanoma, and Traumatic Brain Injury/Psychological Health; $33 million for Spinal Cord Injury; $25 million for Neurofibromatosis; and targeted allocations for Lupus ($10 million), Tick-Borne Disease ($7 million), Hearing Restoration ($5 million), and 20 additional programs.
How to Position for CDMRP Funding
CDMRP operates differently from NIH. Funding announcements arrive on a rolling basis as each of the 34 programs becomes ready to accept applications. Researchers should subscribe to program-specific notifications through the eBRAP portal immediately to receive alerts when their areas open.
Applications flow through Grants.gov under CFDA 12.420, but the process begins at eBRAP, where pre-proposals and full applications are managed. Unlike many federal programs, CDMRP explicitly funds research benefiting both military personnel and civilians, broadening eligibility to academic medical centers, hospitals, and private research institutions nationwide. The U.S. Army Medical Research and Development Command administers all grants with oversight from the Defense Health Agency.
A Strong Signal for Medical Researchers
The restoration to $1.27 billion signals robust congressional support after years of budget uncertainty. With solicitations rolling out throughout 2026, researchers in oncology, neuroscience, musculoskeletal medicine, and military health should begin assembling teams and identifying collaborators now. Program-by-program funding details and deadline tracking are available at grantedai.com.